New rotavirus vaccines seem safer, studies find

January 14, 2014 by Marilynn Marchione

Researchers say that newer vaccines against rotavirus, a severe diarrheal disease in children, appear safer than an earlier one that was pulled from the market 15 years ago.

The new vaccines slightly raise the risk of a twisted bowel problem that doomed the first vaccine, but to a much smaller degree. Doctors say the benefits of the new vaccines, which came out in 2006 and 2008, greatly outweigh the small risk of the bowel problem.

Rotavirus kills more than 400,000 a year, mostly in . In the United States, good medical care usually keeps it from being fatal, but it causes many hospitalizations.

The vaccine safety studies were published online Tuesday by the New England Journal of Medicine.

Explore further: Study shows updated rotavirus vaccine not linked to increase in bowel obstruction

Related Stories

Study shows updated rotavirus vaccine not linked to increase in bowel obstruction

January 4, 2012
The rotovirus vaccine was pulled from the marketplace in 1999 after being associated with painful gastrointestinal complications, however, the updated rotavirus vaccines do not appear to increase the occurrence of these potentially ...

Australian study: Rotavirus vaccine increases the risk of intussusception, but benefits of vaccine outweigh risks

October 2, 2013
Both of the currently available rotavirus vaccines in Australia are associated with a small increase in the risk of intussusception in young infants, according to new research by the Institute and the National Centre for ...

Rotavirus vaccination leads to large decreases in health care costs, doctor visits

September 22, 2011
(Medical Xpress) -- Vaccinating infants against rotavirus has resulted in dramatic decreases in health care use and treatment costs for diarrhea-related illness in U.S. infants and young children, according to a new study ...

Rotavirus vaccine given to newborns in Africa is effective

June 17, 2013
Mayo Clinic and other researchers have shown that a vaccine given to newborns is at least 60 percent effective against rotavirus in Ghana. Rotavirus causes fever, vomiting and diarrhea, which in infants can cause severe dehydration. ...

Engineered rice protects against rotavirus infection

August 8, 2013
For children and immune compromised adults in developing countries, diarrheal disease induced by rotavirus can be life threatening. Current rotaviral vaccines are highly effective in the Western world, but are not as effective ...

Recommended for you

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

Price tag on gene therapy for rare form of blindness: $850K

January 3, 2018
A first-of-its kind genetic treatment for blindness will cost $850,000 per patient, making it one of the most expensive medicines in the world and raising questions about the affordability of a coming wave of similar gene-targeting ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.